Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Visualization of spatiotemporal dynamics of human glioma stem cell invasion.

Tamura R, Miyoshi H, Sampetrean O, Shinozaki M, Morimoto Y, Iwasawa C, Fukaya R, Mine Y, Masuda H, Maruyama T, Narita M, Saya H, Yoshida K, Okano H, Toda M.

Mol Brain. 2019 May 6;12(1):45. doi: 10.1186/s13041-019-0462-3.

2.

Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.

Suina K, Tsuchihashi K, Yamasaki J, Kamenori S, Shintani S, Hirata Y, Okazaki S, Sampetrean O, Baba E, Akashi K, Mitsuishi Y, Takahashi F, Takahashi K, Saya H, Nagano O.

Cancer Sci. 2018 Dec;109(12):3874-3882. doi: 10.1111/cas.13826. Epub 2018 Nov 5.

3.

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer.

Hosonaga M, Arima Y, Sampetrean O, Komura D, Koya I, Sasaki T, Sato E, Okano H, Kudoh J, Ishikawa S, Saya H, Ishikawa T.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2158. doi: 10.3390/ijms19082158.

4.

Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.

Shiota M, Naya M, Yamamoto T, Hishiki T, Tani T, Takahashi H, Kubo A, Koike D, Itoh M, Ohmura M, Kabe Y, Sugiura Y, Hiraoka N, Morikawa T, Takubo K, Suina K, Nagashima H, Sampetrean O, Nagano O, Saya H, Yamazoe S, Watanabe H, Suematsu M.

Nat Commun. 2018 Apr 19;9(1):1561. doi: 10.1038/s41467-018-03899-1.

5.

Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.

Harigai R, Sakai S, Nobusue H, Hirose C, Sampetrean O, Minami N, Hata Y, Kasama T, Hirose T, Takenouchi T, Kosaki K, Kishi K, Saya H, Arima Y.

Sci Rep. 2018 Apr 17;8(1):6069. doi: 10.1038/s41598-018-24484-y.

6.

CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake.

Kobayashi N, Okazaki S, Sampetrean O, Irie J, Itoh H, Saya H.

Sci Rep. 2018 Feb 12;8(1):2785. doi: 10.1038/s41598-018-20973-2.

7.

Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality.

Kitagawa M, Liao PJ, Lee KH, Wong J, Shang SC, Minami N, Sampetrean O, Saya H, Lingyun D, Prabhu N, Diam GK, Sobota R, Larsson A, Nordlund P, McCormick F, Ghosh S, Epstein DM, Dymock BW, Lee SH.

Nat Commun. 2017 Dec 19;8(1):2200. doi: 10.1038/s41467-017-02287-5.

8.

Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.

Shibao S, Minami N, Koike N, Fukui N, Yoshida K, Saya H, Sampetrean O.

Neuro Oncol. 2018 Feb 19;20(3):343-354. doi: 10.1093/neuonc/nox170.

9.

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors.

Minami N, Maeda Y, Shibao S, Arima Y, Ohka F, Kondo Y, Maruyama K, Kusuhara M, Sasayama T, Kohmura E, Saya H, Sampetrean O.

Cancer Med. 2017 Nov;6(11):2635-2645. doi: 10.1002/cam4.1174. Epub 2017 Oct 4.

10.

Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.

Haryu S, Saito R, Jia W, Shoji T, Mano Y, Sato A, Kanamori M, Sonoda Y, Sampetrean O, Saya H, Tominaga T.

J Neurooncol. 2018 Jan;136(1):23-31. doi: 10.1007/s11060-017-2621-7. Epub 2017 Sep 19.

PMID:
28929335
11.

Modeling phenotypes of malignant gliomas.

Sampetrean O, Saya H.

Cancer Sci. 2018 Jan;109(1):6-14. doi: 10.1111/cas.13351. Epub 2017 Nov 15. Review.

12.

Endothelium-induced three-dimensional invasion of heterogeneous glioma initiating cells in a microfluidic coculture platform.

Chonan Y, Taki S, Sampetrean O, Saya H, Sudo R.

Integr Biol (Camb). 2017 Sep 18;9(9):762-773. doi: 10.1039/c7ib00091j.

PMID:
28752870
13.

Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.

Kikuchi R, Sampetrean O, Saya H, Yoshida K, Toda M.

J Neurooncol. 2017 Jun;133(2):297-307. doi: 10.1007/s11060-017-2457-1. Epub 2017 May 29.

PMID:
28555424
14.

Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.

Sato A, Mizobuchi Y, Nakajima K, Shono K, Fujihara T, Kageji T, Kitazato K, Matsuzaki K, Mure H, Kuwayama K, Sumi A, Saya H, Sampetrean O, Nagahirao S.

J Neurooncol. 2017 Apr;132(2):231-238. doi: 10.1007/s11060-017-2380-5. Epub 2017 Mar 10.

PMID:
28283800
15.

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.

Sato R, Nakano T, Hosonaga M, Sampetrean O, Harigai R, Sasaki T, Koya I, Okano H, Kudoh J, Saya H, Arima Y.

Biomed Res Int. 2017;2017:8032910. doi: 10.1155/2017/8032910. Epub 2017 Jan 22.

16.

[p53 mutations in brain tumors].

Maeda Y, Sampetrean O, Saya H.

Nihon Rinsho. 2016 Sep;74 Suppl 7:112-116. Japanese. No abstract available.

PMID:
30634739
17.

Histopathological investigation of glioblastomas resected under bevacizumab treatment.

Tamura R, Tanaka T, Miyake K, Tabei Y, Ohara K, Sampetrean O, Kono M, Mizutani K, Yamamoto Y, Murayama Y, Tamiya T, Yoshida K, Sasaki H.

Oncotarget. 2016 Aug 9;7(32):52423-52435. doi: 10.18632/oncotarget.9387.

18.

Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts.

Umeyama K, Watanabe K, Watanabe M, Horiuchi K, Nakano K, Kitashiro M, Matsunari H, Kimura T, Arima Y, Sampetrean O, Nagaya M, Saito M, Saya H, Kosaki K, Nagashima H, Matsumoto M.

Sci Rep. 2016 Apr 14;6:24413. doi: 10.1038/srep24413.

19.

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).

Tsuchihashi K, Okazaki S, Ohmura M, Ishikawa M, Sampetrean O, Onishi N, Wakimoto H, Yoshikawa M, Seishima R, Iwasaki Y, Morikawa T, Abe S, Takao A, Shimizu M, Masuko T, Nagane M, Furnari FB, Akiyama T, Suematsu M, Baba E, Akashi K, Saya H, Nagano O.

Cancer Res. 2016 May 15;76(10):2954-63. doi: 10.1158/0008-5472.CAN-15-2121. Epub 2016 Mar 15.

20.

Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.

Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon CH, Saya H, Nakano I, Pizzo DP, VandenBerg SR, Chen CC.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4055-64. doi: 10.1073/pnas.1501967112. Epub 2015 Jul 9.

21.

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.

Saga I, Shibao S, Okubo J, Osuka S, Kobayashi Y, Yamada S, Fujita S, Urakami K, Kusuhara M, Yoshida K, Saya H, Sampetrean O.

Neuro Oncol. 2014 Aug;16(8):1048-56. doi: 10.1093/neuonc/nou096. Epub 2014 May 23.

22.

Characteristics of glioma stem cells.

Sampetrean O, Saya H.

Brain Tumor Pathol. 2013 Oct;30(4):209-14. doi: 10.1007/s10014-013-0141-5. Epub 2013 Apr 13. Review.

PMID:
23584571
23.

IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells.

Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano S, Matsumura A, Saya H.

Stem Cells. 2013 Apr;31(4):627-40. doi: 10.1002/stem.1328.

24.

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells.

Sampetrean O, Saga I, Nakanishi M, Sugihara E, Fukaya R, Onishi N, Osuka S, Akahata M, Kai K, Sugimoto H, Hirao A, Saya H.

Neoplasia. 2011 Sep;13(9):784-91.

25.

Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model.

Kai K, Nagano O, Sugihara E, Arima Y, Sampetrean O, Ishimoto T, Nakanishi M, Ueno NT, Iwase H, Saya H.

Cancer Sci. 2009 Dec;100(12):2275-82. doi: 10.1111/j.1349-7006.2009.01318.x. Epub 2009 Aug 19.

26.

Reversible whole-organism cell cycle arrest in a living vertebrate.

Sampetrean O, Iida S, Makino S, Matsuzaki Y, Ohno K, Saya H.

Cell Cycle. 2009 Feb 15;8(4):620-7. Epub 2009 Feb 6.

PMID:
19182528
27.

[Endosaccular embolization of an intrasellar aneurysm with hypopituitarism: case report].

Fujii M, Tone O, Tomita H, Tamaki M, Akimoto H, Shigeta K, Sampetrean O, Kanno K, Matsushita M.

No Shinkei Geka. 2008 Apr;36(4):329-37. Review. Japanese.

PMID:
18411798
28.

Rapidly growing dysembryoplastic neuroepithelial tumor: case report.

Sampetrean O, Maehara T, Arai N, Nemoto T.

Neurosurgery. 2006 Dec;59(6):E1337-8; discussion E1338.

PMID:
17277670
29.

Coil Embolization for Ruptured Cerebral Aneurysms of 2x3 mm Diameter.

Tone O, Tomita H, Tamaki M, Akimoto H, Shigeta K, Sampetrean O, Fujii M.

Interv Neuroradiol. 2006 Jan 20;12(Suppl 1):97-100. Epub 2006 Jun 15.

30.

Endovascular surgery as the first-choice treatment for ruptured cerebral aneurysms: how far has it come?

Tone O, Tomita H, Tamaki M, Satoh Y, Matsuoka Y, Sampetrean O, Nakabayashi M, Katsumi A, Suzaki S.

Interv Neuroradiol. 2004 Dec 24;10 Suppl 2:41-7. Epub 2008 May 15.

Supplemental Content

Loading ...
Support Center